CSCI COSCIENS Biopharma
- 4.105
- +0.055+1.36%
COSCIENS Biopharma News
COSCIENS Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
AEterna Zentaris | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
AEterna Zentaris | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AEterna Zentaris | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
AEterna Zentaris | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
AEterna Zentaris | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
